The tetra-peptide anti-wrinkle solutions market is projected to grow from USD 1,752.3 million in 2025 to USD 5,741.1 million by 2035, at a CAGR of 12.6%. Anti-aging & wrinkle reduction will dominate with a 60.6% market share, while signal peptides will lead the peptide type segment with a 52.5% share.